Navigation Links
Risperdal Litigation Scheduled to Convene at September Meeting in Philadelphia Court of Common Pleas, Bernstein Liebhard LLP Reports
Date:8/16/2014

cleared by the U.S. Food and Drug Administration (FDA) to treat irritability in children ages 5-to-16 years old with autistic disorder. According to research, Risperdal is also frequently prescribed off-label for symptoms associated with ADHD.

As Risperdal lawsuits alleging male gynecomastia continue to be filed in the Philadelphia Common Pleas, a report published this month lends evidence to the association between Risperdal and this particular complication. According to a study published on August 6th in the Journal of Clinical Psychopharmacology, 27 out of 174 men exposed to risperidone, the active ingredient in Risperdal, developed male breasts within 60 days. The research was led by scientists from the University of British Columbia and involved health records of more than 82,000 men from 2001 to 2011. The men were aged between 40 and 85 years old.*

According to Risperdal lawsuits filed in the Philadelphia Court of Common Pleas, Johnson & Johnson and Janssen failed to adequately warn men and their doctors about the risk for gynecomastia and other side effects. The companies have also been accused of marketing the drug for off-label uses.

In November 2013, Johnson & Johnson agreed to a $2.5 million settlement with the U.S. Department of Justice involving claims that Risperdal and several other medications were promoted for uses not approved by the FDA. In the case for Risperdal, this may involve promotion of the drug’s marketing in children before it was cleared for pediatric uses in 2006. The federal government also accused Johnson & Johnson and Janssen of withholding information about Risperdal’s side effects, which may include its association with gynecomastia.

Men and young boys who developed gyn
'/>"/>

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Parker Waichman LLP Commends Arkansas Attorney General for Backing Fine Against Johnson & Johnson over Risperdal Off-Label Marketing Allegations
2. The Consumer Justice Foundation Launches RisperdalLaw.com, an Informational Web Site Dealing with Alleged Risperdal Side Effects Including Gynecomastia
3. Bernstein Liebhard LLP Investigating Risperdal Lawsuits on Behalf of Victims of Male Breast Growth Allegedly Caused by Risperdal
4. New Risperdal Lawsuit Filed in Pennsylvania Litigation; Alleges Male Breast Growth Injuries Caused by Anti-Psychotic Medication, Bernstein Liebhard LLP Reports
5. Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Settlement in Risperdal Marketing Investigation
6. Risperdal Lawsuits: $2.2 Billion Settlement Between Federal Government, Johnson & Johnson Over Alleged Illegal Marketing of Risperdal, Other Medications
7. Risperdal Lawsuit News: Johnson & Johnson To Pay Over $2.2 Billion In Risperdal and Invega Settlement Draws Comment From Wright & Schulte LLC
8. J&J to Pay $2.2B to Settle Allegations Over Its Marketing of Risperdal; Parker Waichman LLP Applauds Efforts of Whistleblowers in Helping Compel Resolution
9. Risperdal Lawsuit News: Rottenstein Law Group LLP Comments on $2 Billion Risperdal Settlement Report
10. Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Mounting Claims Involving Risperdal Gynecomastia Allegations in Pennsylvania Litigation
11. Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Release of Emails from Johnson & Johnson’s Janssen Subsidiary in Federal Risperdal Settlement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2015)... (PRWEB) , ... August 31, 2015 , ... ... jobs and a third of tax receipts, issues that are critically important to ... have bands of attorneys and lobbyists monitoring proposed legislation and changing tax and ...
(Date:8/30/2015)... ... August 31, 2015 , ... ... Cooking Magazine for Kids , recently elected two new officers to serve on ... further ChopChop’s mission of inspiring and teaching kids to cook real food with ...
(Date:8/30/2015)... Auckland, NZ (PRWEB) , ... August 30, 2015 ... ... enterprise collaboration across platforms and devices, today announced it is a Silver Sponsor ... 1, 2015 at Sky City Convention Centre in Auckland, NZ. Throughout the event, ...
(Date:8/30/2015)... ... 30, 2015 , ... InHealth Media ( http://www.inhealthmedia.com ) announced ... Director for InHealth Media. Mr. Spector comes with a wide array of ... on-air television, producing shows, on air-radio and media relations. , Brian joins ...
(Date:8/30/2015)... ... 30, 2015 , ... Nutritional Products International ( http://www.nutricompany.com ) ... global cosmeceutical and skin care brands. Mr. Fernandez comes with a wide ... working in operations, purchasing and management for some of the nations biggest retail ...
Breaking Medicine News(10 mins):Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 2Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 3Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 4Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 2Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 3Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 2Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 3Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 4Health News:InHealth Media Appoints New Global Communications Director 2Health News:NPI Executive Vice President Leads Cosmeceutical Expansion 2
... Dec. 4 Accuray Incorporated,(Nasdaq: ARAY ), a ... company has hired Derek Bertocci as its chief financial officer. ... been serving as the chief financial officer of BioForm,Medical, Inc., ... October 2006, will begin at Accuray on January 1,2009. , ...
... bring sports flavor to the conversation about a serious men,s health ... ... -- College basketball analyst and sports ambassador Dick Vitale and co-host ... ESPN, The V Foundation for Cancer Research® and Stand Up To ...
... Dec. 4 Decision Resources, one of the,world,s ... and,healthcare issues, finds that Eisai/Helsinn Healthcare,s Aloxi,s marketing,message ... the most influential,by oncologists in the chemotherapy-induced nausea ... with the brand,highlighting the strength of the Aloxi ...
... , VALENCIA, Calif., Dec. 4 ... has met the primary endpoints of its final two pivotal Phase 3 ... company expects to disclose more details of the top-line data from these ... and 102) by mid-December. , , ...
... about a serious men,s health threat , ... basketball analyst and sports ambassador Dick Vitale and co-host of ... with ESPN, The V Foundation for Cancer Research(R) and Stand ... discussion about the often ignored reality of prostate cancer and ...
... Inc.,(NYSE: NUS ) today announces its 2009 financial ... at 9 a.m. at the Grand Hyatt,Hotel in New York ... operational results and outline plans,for 2009. , ... and we look forward to rounding out 2008,on a positive ...
Cached Medicine News:Health News:Accuray Hires Chief Financial Officer 2Health News:Accuray Hires Chief Financial Officer 3Health News:ESPN'S Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer 2Health News:ESPN'S Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer 3Health News:ESPN'S Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer 4Health News:Oncologists Rank Aloxi's Marketing Message Most Influential in the Chemotherapy-Induced Nausea and Vomiting Drug Market 2Health News:MannKind Reports Positive Results from Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes 2Health News:MannKind Reports Positive Results from Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes 3Health News:ESPN's Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer 2Health News:ESPN's Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer 3Health News:ESPN's Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer 4Health News:Nu Skin Enterprises Offers 2009 Guidance During Annual Investor Day 2Health News:Nu Skin Enterprises Offers 2009 Guidance During Annual Investor Day 3
(Date:8/30/2015)... Massachusetts y LONDRES, August 30, 2015 /PRNewswire/ ... ofrece una visión holística de l ... todo el trayecto   ... hoy el debut europeo de IntelliSpace Cardiovascular , ... que ofrece sofisticadas herramientas para acceder, analizar y compartir ...
(Date:8/29/2015)... August 29, 2015 La ... para los sistemas de imagen por Ultrasonidos   ofrece ... de examen rápidos y un flujo de trabajo   ... en el proceso de detección de Cardiopatías   ... anunciado hoy el lanzamiento europeo de HeartModel A.I ...
(Date:8/28/2015)... , Aug. 28, 2015  With the heroin ... reaching deadlier heights, Jacksonville -based Lakeview ... Hemphill is helping to explain why fentanyl is ... approximately 40 to 50 times more potent than pharmaceutical ... users as heroin, the risk of death skyrockets. ...
Breaking Medicine Technology:Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 2Philips presenta HeartModel A.I en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 4Philips presenta HeartModel A.I en el Congreso ESC 2015 5Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2
... N.J., Oct. 4 Medco Health Solutions, Inc. ... its third-quarter 2010 financial results in a press ... 2, 2010.   (Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO) ... management will hold a conference call at 8:30 ...
... VIVUS, Inc. (Nasdaq: VVUS ) today ... agreement with Meda - an international specialty pharma company ... erectile dysfunction (ED).  Under the agreement, Meda will acquire ... MUSE patents, existing inventory and the manufacturing facility located ...
Cached Medicine Technology:Medco Announces Date for Third-Quarter 2010 Financial Results 2VIVUS Announces Sale of MUSE Assets to Meda 2VIVUS Announces Sale of MUSE Assets to Meda 3
The adult underbody blanket is conveniently positioned on the table before the patient arrives to the procedure suite....
The cardiac access blanket helps maintain normothermia and allows unrestricted access to the patient....
The full access underbody blanket is positioned on the procedure table before the patient arrives to the room....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
Medicine Products: